Lipid classes and fatty acid patterns are altered in the brain of γ-synuclein null mutant mice

Lipids

Volumn 46, Issue 2, 2011, Pages 121-130

  Guschina, Irina ^a   Millership, Steve ^a   O'Donnell, Valerie ^b   Ninkina, Natalia ^a   Harwood, John ^a   Buchman, Vladimir ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

Synuclein null mutant mice; Cortex; Docosahexaenoic acid; Lipid composition; Midbrain; Phosphatidylserine; Synuclein

Indexed keywords

DOCOSAHEXAENOIC ACID; FATTY ACID; GAMMA SYNUCLEIN; LIPID; PHOSPHATIDYLETHANOLAMINE; PHOSPHATIDYLSERINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN REGION; CONTROLLED STUDY; DIET; FATTY ACID ANALYSIS; LIPID ANALYSIS; LIPID COMPOSITION; LIPID METABOLISM; MALE; MOUSE; MOUSE MUTANT; NONHUMAN; PLASMA; PROTEIN DEFICIENCY; WILD TYPE;

ALPHA-SYNUCLEIN; ANIMALS; CEREBRAL CORTEX; DISEASE MODELS, ANIMAL; FATTY ACIDS; GAMMA-SYNUCLEIN; MALE; MESENCEPHALON; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NEURODEGENERATIVE DISEASES; NEURONS;

MUS;

EID: 79952313703     PISSN: 00244201     EISSN: 15589307     Source Type: Journal    
DOI: 10.1007/s11745-010-3486-0     Document Type: Article

References (71)

1. C Lavedan 2008 The synuclein family Genome Res 8 871 880
2. MH Polymeropoulos C Lavedan E Leroy SE Ide A Dehejia A Dutra B Pike H Root J Rubenstein R Boyer ES Stenroos S Chandrasekharappa A Athanassiadou T Papapetropoulos WG Johnson AM Lazzarini RC Duvoisin G Di Iorio LI Golbe RL Nussbaum 1997 Mutation in the alpha-synuclein gene identified in families with Parkinson's disease Science 276 2045 2047 1:CAS:528:DyaK2sXkt1altr4%3D 10.1126/science.276.5321.2045 9197268 (Pubitemid 27443610)
3. R Kruger W Kuhn T Muller D Woitalla M Graeber S Kosel H Przuntek JT Epplen L Schols O Riess 1998 Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease Nat Genet 18 106 108 1:CAS:528: DyaK1cXosFCntA%3D%3D 10.1038/ng0298-106 9462735
4. AB Singleton, et al. 2003 alpha-Synuclein locus triplication causes Parkinson's disease Science 302 841 1:CAS:528:DC%2BD3sXoslehsbc%3D 10.1126/science.1090278 14593171 (Pubitemid 37339619)
5. MC Chartier-Harlin J Kachergus C Roumier V Mouroux X Douay S Lincoln C Levecque L Larvor J Andrieux M Hulihan N Waucquier L Defebvre P Amouyel M Farrer A Destee 2004 Alpha-synuclein locus duplication as a cause of familial Parkinson's disease Lancet 364 1167 1169 1:CAS:528:DC%2BD2cXnvVOiu7Y%3D 10.1016/S0140-6736(04)17103-1 15451224 (Pubitemid 39296604)
6. P Ibanez AM Bonnet B Debarges E Lohmann F Tison P Pollak Y Agid A Durr A Brice 2004 Causal relation between alpha-synuclein gene duplication and familial Parkinson's disease Lancet 364 1169 1171 1:CAS:528:DC%2BD2cXnvVOiu7c%3D 10.1016/S0140-6736(04)17104-3 15451225 (Pubitemid 39296605)
7. JJ Zarranz J Alegre JC Gomez-Esteban E Lezcano R Ros I Ampuero L Vidal J Hoenicka O Rodriguez B Atares V Llorens E Gomez Tortosa T del Ser DG Munoz JG de Yebenes 2004 The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia Ann Neurol 55 164 173 1:CAS:528:DC%2BD2cXhs1Sgtb0%3D 10.1002/ana.10795 14755719 (Pubitemid 38166992)
8. DM Kay SA Factor A Samii DS Higgins A Griffith JW Roberts BC Leis JG Nutt JS Montimurro RG Keefe AJ Atkins D Yearout CP Zabetian H Payami 2008 Genetic association between alpha-synuclein and idiopathic Parkinson's disease Am J Med Genet B Neuropsychiatr Genet 147B 1222 1230 10.1002/ajmg.b.30758 18404644
9. I Mizuta T Tsunoda W Satake Y Nakabayashi M Watanabe A Takeda K Hasegawa K Nakashima M Yamamoto N Hattori M Murata T Toda 2008 Calbindin 1, fibroblast growth factor 20, and alpha-synuclein in sporadic Parkinson's disease Hum Genet 124 89 94 1:CAS:528:DC%2BD1cXot1Wht74%3D 10.1007/s00439-008-0525-5 18568448
10. N Pankratz JB Wilk JC Latourelle AL DeStefano C Halter EW Pugh KF Doheny JF Gusella WC Nichols T Foroud RH Myers 2009 Genomewide association study for susceptibility genes contributing to familial Parkinson disease Hum Genet 124 593 605 1:CAS:528:DC%2BD1cXhsFWrsr%2FI 10.1007/s00439-008-0582-9 18985386
11. SW Scholz, et al. 2009 SNCA variants are associated with increased risk for multiple system atrophy Ann Neurol 65 610 614 1:CAS:528:DC%2BD1MXnvFahsb8%3D 10.1002/ana.21685 19475667
12. GT Sutherland GM Halliday PA Silburn FL Mastaglia DB Rowe RS Boyle JD O'Sullivan T Ly SD Wilton GD Mellick 2009 Do polymorphisms in the familial Parkinsonism genes contribute to risk for sporadic Parkinson's disease? Mov Disord 24 833 838 10.1002/mds.22214 19224617
13. B Caughey PT Lansbury 2003 Protofibrils, pores, fibrils, and neurodegeneration: separating the responsible protein aggregates from the innocent bystanders Annu Rev Neurosci 26 267 298 1:CAS:528:DC%2BD3sXntFSisL0%3D 10.1146/annurev.neuro.26.010302.081142 12704221 (Pubitemid 37064935)
14. KK Dev K Hofele S Barbieri VL Buchman H van der Putten 2003 Part II: alpha-synuclein and its molecular pathophysiological role in neurodegenerative disease Neuropharmacology 45 14 44 1:CAS:528:DC%2BD3sXks1alsrw%3D 10.1016/S0028-3908(03)00140-0 12814657 (Pubitemid 36695009)
15. AL Fink 2006 The aggregation and fibrillation of alpha-synuclein Acc Chem Res 39 628 634 1:CAS:528:DC%2BD28XptFaitrc%3D 10.1021/ar050073t 16981679
16. VN Uversky 2007 Neuropathology, biochemistry, and biophysics of alpha-synuclein aggregation J Neurochem 103 17 37 1:CAS:528:DC%2BD2sXhtF2qu7nM 17623039 (Pubitemid 47407730)
17. E Jo J McLaurin CM Yip P St George-Hyslop PE Fraser 2000 α-Synuclein membrane interactions and lipid specificity J Biol Chem 275 34328 34334 1:CAS:528:DC%2BD3cXotFWlsL8%3D 10.1074/jbc.M004345200 10915790
18. WS Davidson A Jonas AW Poon KA Conway G Browne 1998 Stabilization of α-synuclein secondary structure upon binding to synthetic membranes J Biol Chem 273 9443 9449 1:CAS:528:DyaK1cXivVOrs7s%3D 10.1074/jbc.273.16.9443 9545270 (Pubitemid 28183026)
19. M Ramakrishnan PH Jensen D Marsh 2003 α-Synuclein associated with phosphatidylglycerol probed by lipid spin labels Biochemistry 42 12919 12926 1:CAS:528:DC%2BD3sXotVKlsbY%3D 10.1021/bi035048e 14596606 (Pubitemid 37385823)
20. VN Uversky J Li P Souillac IS Millett S Doniach R Jakes M Goedert AL Fink 2002 Biophysical properties of the synucleins and their propensities to fibrillate J Biol Chem 277 11970 11978 1:CAS:528:DC%2BD38XivVektrw%3D 10.1074/jbc.M109541200 11812782 (Pubitemid 34952757)
21. NB Cole DD Murphy T Grider S Rueter D Brasaemle RL Nussbaum 2002 Lipid droplet binding and oligomerization properties of the Parkinson's disease protein α-synuclein J Biol Chem 277 6344 6352 1:CAS:528: DC%2BD38XhvFyru7c%3D 10.1074/jbc.M108414200 11744721 (Pubitemid 34968427)
22. DL Fortin MD Troyer K Nakamura S-I Kubo MD Anthony RH Edwards 2004 Lipid rafts mediate the synaptic localization of α-synuclein J Neurosci 28 6715 6723 10.1523/JNEUROSCI.1594-04.2004 (Pubitemid 38993891)
23. S Kubo VM Nemani RJ Chalkley MD Anthony N Hattori Y Mizuno RH Edwards DL Fortin 2005 A combinatorial code for the interaction of α-synuclein with membranes J Biol Chem 280 31664 31672 1:CAS:528:DC%2BD2MXpslejs74%3D 10.1074/jbc.M504894200 16020543 (Pubitemid 41291913)
24. Z Martinez M Zhu S Han AL Fink 2007 GM1 specifically interacts with α-synuclein and inhibits fibrillation Biochem 46 1868 1877 1:CAS:528:DC%2BD2sXot1WqtA%3D%3D 10.1021/bi061749a
25. ED Pasquale J Fantini H Chahinian M Maresca N Taïeb N Yahi 2010 Altered ion channel formation by the Parkinson's-disease-linked E46K mutant of α-synuclein is correlated by GM3 but not GM1 gangliosides J Mol Biol 397 202 218 10.1016/j.jmb.2010.01.046 20114052
26. RJ Perrin WS Woods DF Clayton JM George 2001 Exposure to long chain polyunsaturated fatty acids triggers rapid multimerization of synucleins J Biol Chem 276 41958 41962 1:CAS:528:DC%2BD3MXosVGntLc%3D 10.1074/jbc.M105022200 11553616 (Pubitemid 37371096)
27. R Sharon I Bar-Joseph MP Frosch DM Walsh JA Hamilton DJ Selkoe 2003 The formation of highly soluble oligomers of α-synuclein is regulated by fatty acids and enhanced in Parkinson's disease Neuron 37 583 595 1:CAS:528:DC%2BD3sXhvFelt7o%3D 10.1016/S0896-6273(03)00024-2 12597857 (Pubitemid 36262981)
28. R Sharon I Bar-Joseph GE Mirick CN Serhan DJ Selkoe 2003 Altered fatty acid composition of dopaminergic neurons expressing α-synuclein and human brains with α-synucleinopathies J Biol Chem 278 49874 49881 1:CAS:528:DC%2BD3sXpslSru7o%3D 10.1074/jbc.M309127200 14507911 (Pubitemid 37548822)
29. RC Valentine DL Valentine 2004 Omega-3 fatty acids in cellular membranes: a unified concept Prog Lipid Res 43 383 402 1:CAS:528:DC%2BD2cXotF2hu70%3D 10.1016/j.plipres.2004.05.004 15458813 (Pubitemid 39348977)
30. A Maldjian C Cristofori RC Noble BK Speake 1996 The fatty acid composition of brain phospholipids from chicken and duck embryos Comp Biochem Physiol B Biochem Mol Biol 115 153 158 1:STN:280:DyaK2s%2FptlCgsQ%3D%3D 10.1016/0305-0491(96)00086-7 8938995 (Pubitemid 26364288)
31. N Salem Jr T Moriguchi RS Greiner K McBride A Ahmad JN Catalan B Slotnick 2001 Alterations in brain function after loss of docosahexaenoate due to dietary restriction of n-3 fatty acids J Mol Neurosci 16 299 308 1:CAS:528:DC%2BD3MXltlars70%3D 10.1385/JMN:16:2-3:299 11478385 (Pubitemid 32664792)
32. JM Bourre M Francois A Youyou O Dumont M Piciotti G Pascal G Durand 1989 The effects of dietary alpha-linolenic acid on the composition of nerve membranes, enzymatic activity, amplitude of electrophysiological parameters, resistance to poisons and performance of learning tasks in rats J Nutr 119 1880 1892 1:CAS:528:DyaK3cXhtlyjsbo%3D 2576038 (Pubitemid 20063881)
33. G Barceló-Coblijn EJ Murphy 2009 Alpha-linolenic acid and its conversion to longer chain n-3 fatty acids: benefits for human health and a role in maintaining tissue n-3 fatty acid levels Prog Lipid Res 48 355 374 10.1016/j.plipres.2009.07.002
34. P Willatts JS Forsyth MK Di Midugno S Varma M Colvin 1998 Effect of long-chain polyunsaturated fatty acids in infant formula on problem solving at 10 months of age Lancet 352 688 691 1:CAS:528:DyaK1cXmtVWru7s%3D 10.1016/S0140-6736(97)11374-5 9728984 (Pubitemid 28398703)
35. M Martinez 1990 Severe deficiency of docosahexaenoic acid in peroxisomal disorders: a defect of delta 4 desaturation? Neurology 40 1292 1298 1:STN:280:DyaK3czktVGjug%3D%3D 2143272 (Pubitemid 20244997)
36. M Soderberg C Edlund K Kristensson G Dallner 1991 Fatty acid composition of brain phospholipids in aging and Alzheimer's disease Lipids 26 421 425 1:STN:280:DyaK3MzltV2rug%3D%3D 10.1007/BF02536067 1881238
37. CR Hooijmans AJ Kiliaan 2008 Fatty acids, lipid metabolism and Alzheimer pathology Eur J Pharm 585 176 196 1:CAS:528:DC%2BD1cXls1Sjsrs%3D 10.1016/j.ejphar.2007.11.081
38. K Kitajka LG Puskas A Zvara L Hackler G Barcelo-Coblijn YK Yeo 2002 The role of n-3 polyunsaturated fatty acids in brain: modulation of rat brain gene expression by dietary fatty acids PNAS 99 2619 2624 1:CAS:528: DC%2BD38Xit1CrsLk%3D 10.1073/pnas.042698699 11880617 (Pubitemid 34240510)
39. M Cansev IH Ulus L Wang TJ Maher RJ Wurtman 2008 Restorative effects of uridine plus docosahexaenoic acid in a rat model of Parkinson's disease Neurosci Res 62 206 209 1:CAS:528:DC%2BD1cXht1Sit73J 10.1016/j.neures.2008.07.005 18761383
40. M Bousquet M Saint-Pierre C Julien C Salem Jr F Gicchetti F Calon 2008 Beneficial effects of dietary omega-3 polyunsaturated fatty acid on toxin-induced neuronal degeneration in an animal model of Parkinson's disease FASEB J 22 1213 1225 1:CAS:528:DC%2BD1cXktlWntrk%3D 10.1096/fj.07-9677com 18032633 (Pubitemid 351519975)
41. G Barceló-Coblijn MY Golovko I Weinhofer J Berger EJ Murphy 2007 Brain neutral lipid mass is increased in α-synuclein gene-ablated mice J Neurochem 101 132 141 10.1111/j.1471-4159.2006.04348.x 17250686 (Pubitemid 46426471)
42. CE Ellis EJ Murphy DC Mitchell MY Golovko FS Scaglia G Barceló-Coblijn RL Nussbaum 2005 Mitochondrial lipid abnormality and electron transport chain impairment in mice lacking α-synuclein Mol Cell Biol 25 10190 10201 1:CAS:528:DC%2BD2MXht1altrbJ 10.1128/MCB.25.22.10190-10201. 2005 16260631 (Pubitemid 41572763)
43. MY Golovko TA Rosenberger NJ Faergeman S Feddersen NB Cole I Pribill J Berger RL Nussbaum EJ Murphy 2006 Acyl-CoA synthetase activity links wild-type wild type but not mutant alpha-synuclein to brain arachidonate metabolism Biochem 45 6956 6966 1:CAS:528:DC%2BD28XksFWitr4%3D 10.1021/bi0600289 (Pubitemid 43856680)
44. PJ Oort TA Knotts M Grino N Naour J-P Bastard K Clément N Ninkina VL Buchman P Permana X Luo G Pan TN Dunn SH Adams 2008 γ-Synuclein is an adipocyte-neuron gene coordinately-expressed with leptin and increased in human obesity J Nutr 135 841 848 (Pubitemid 351571580)
45. PM Frandsen LB Madsen C Bendixen K Larsen 2009 Porcine gamma-synuclein: molecular cloning, expression analysis, chromosomal localization and functional expression Mol Biol Res 36 971 976 1:CAS:528:DC%2BD1MXjvFejsL0%3D 10.1007/s11033-008-9270-z
46. N Ninkina K Papachroni DC Robertson O Schmidt L Delaney F O'Neill F Court A Rosenthal SM Fleetwood-Walker AM Davies VL Buchman 2003 Neurons expressing the highest levels of γ-synuclein are unaffected by targeted inactivation of the gene Mol Cell Biol 23 8233 8245 1:CAS:528:DC%2BD3sXovVKjtrY%3D 10.1128/MCB.23.22.8233-8245.2003 14585981 (Pubitemid 37377513)
47. DC Robertson O Schmidt N Ninkina PA Jones J Sharkey VL Buchman 2004 Developmental loss and resistance to MPTP toxicity of dopaminergic neurons in substantia nigra pars compacta of γ-synuclein, α-synuclein and double α/γ-synuclein null mutant mice J Neurochem 89 1126 1136 1:CAS:528:DC%2BD2cXkvFOktb0%3D 10.1111/j.1471-4159.2004.02378.x 15147505 (Pubitemid 38715830)
48. J Garbus HF De Luca ME Loomans FM Strong 1963 The rapid incorporation of phosphate in mitochondrial lipids J Biol Chem 238 59 63 1:CAS:528: DyaF3sXhs1equw%3D%3D 13946475
49. Kates M (1986) Techniques of lipidology: isolation, analysis and identification of lipids, 2nd edn. Elsevier, Amsterdam
50. AP Simopoulos A Leaf N Salem Jr 2000 Workshop statement on the essentiality of and recommended dietary intakes for omega-6 and omega-3 fatty acids Prostag Leukotr Ess Fatty Acids 63 119 121 1:CAS:528:DC%2BD3cXnslCrt7w%3D 10.1054/plef.2000.0176
51. F-F Hsu A Bohrer J Turk 1998 Electrospray ionization mass spectrometric analysis of sulfatide. Determination of fragmentation patterns and characterization of molecular species expressed in brain and in pancreatic islets Biochim Biophys Acta 1392 202 216 1:CAS:528:DyaK1cXjvVSmsbo%3D 9630631 (Pubitemid 28287325)
52. X Han H Cheng 2005 Characterization and direct quantitation of cerebroside molecular species from lipid extracts by shotgun lipidomics J Lipid Res 46 163 175 1:CAS:528:DC%2BD2MXltlKqtQ%3D%3D 10.1194/jlr.D400022-JLR200 15489545 (Pubitemid 40066682)
53. 2-ceramide in mammalian tissues: possible relationship to etherphospholipids and phosphorylation by ceramide kinase Biol Chem 388 315 3244 10.1515/BC.2007.035 17338639 (Pubitemid 46364471)
54. RM Adibhatla JF Hatcher 2007 Role of lipids in brain injury and diseases Future Lipidol 2 403 422 1:CAS:528:DC%2BD2sXosVShurg%3D 10.2217/17460875.2.4.403 18176634 (Pubitemid 47250149)
55. J Aharon-Peretz H Rosenbaum R Gershoni-Baruch 2004 Mutation in the glucocerebrosidase gene and Parkinson's disease in Ashkenazi Jews N Engl J Med 351 1972 1977 1:CAS:528:DC%2BD2cXps1Wksbc%3D 10.1056/NEJMoa033277 15525722 (Pubitemid 39447138)
56. LN Clark LA Kartsaklis RW Gilbert B Dorado BM Ross S Kisselev M Verbitsky H Mejia-Santana LJ Cote H Andrews J-P Vonsattel S Fahn R Mayeux LS Honig K Marder 2009 Association of glucocerebrosidase mutations with dementia with Lewy bodies Arch Neurol 66 578 583 10.1001/archneurol.2009.54 19433657
57. I Rappley DS Myers SB Milne PT Ivanova MJ LaVoie HA Brown DJ Selkoe 2009 Lipidomic profiling in mouse brain reveals differences between ages and genders, with smaller changes associated with α-synuclein genotype J Neurochem 111 15 25 1:CAS:528:DC%2BD1MXht1ertLjK 10.1111/j.1471-4159.2009.06290.x 19627450
58. S Chandra F Fornai HB Kwon U Yazdani D Atasoy X Liu RE Hammer G Battaglia DC German PE Castillo TC Sudhof 2004 Double-knockout mice for alpha- and beta-synucleins: effect on synaptic functions Proc Natl Acad Sci USA 101 14966 14971 1:CAS:528:DC%2BD2cXovVyisLw%3D 10.1073/pnas.0406283101 15465911 (Pubitemid 39410782)
59. SL Senior N Ninkina R Deacon D Bannerman VL Buchman SJ Cragg R Wade-Martins 2008 Increased striatal dopamine release and hyperdopaminergic-like behaviour in mice lacking both alpha-synuclein and gamma-synuclein Eur J Neurosci 27 947 957 10.1111/j.1460-9568.2008.06055.x 18333965 (Pubitemid 351365167)
60. A Abeliovich Y Schmitz I Farinas D Choi-Lundberg WH Ho PE Castillo N Shinsky JM Verdugo M Armanini A Ryan, et al. 2000 Mice lacking alpha-synuclein display functional deficits in the nigrostriatal dopamine system Neuron 25 239 252 1:CAS:528:DC%2BD3cXhtVWrt74%3D 10.1016/S0896-6273(00)80886-7 10707987 (Pubitemid 30316525)
61. N Nagan RA Zoeller 2001 Plasmalogens: biosynthesis and functions Prog Lipid Res 40 199 229 1:CAS:528:DC%2BD3MXislCktbk%3D 10.1016/S0163-7827(01)00003- 0 11275267 (Pubitemid 32220187)
62. AA Farooqui LA Horrocks T Farooqui 2000 Glycerophospholipids in brain: their metabolism, incorporation into membranes, functions, and involvement in neurological disorders Chem Phys Lipids 106 1 29 1:CAS:528:DC%2BD3cXktlKku7s%3D 10.1016/S0009-3084(00)00128-6 10878232 (Pubitemid 30394588)
63. AA Farooqui SI Rapoport LA Horrocks 1997 Membrane phospholipid alterations in Alzheimer's disease: deficiency of ethanolamine plasmalogens Neurochem Res 22 523 527 1:CAS:528:DyaK2sXislymt7c%3D 10.1023/A:1027380331807 9130265 (Pubitemid 27184719)
64. C Dragonas T Bertsch CC Sieber T Brosche 2009 Plasmalogens as a marker of elevated systematic oxidative stress in Parkinson's disease Clin Chem Lab Med 47 894 897 1:CAS:528:DC%2BD1MXpsFOkt78%3D 10.1515/CCLM.2009.205 19575554
65. A Al-Wandi N Ninkina S Millership SJ Williamson PA Jones VL Buchman 2010 Absence of alpha-synuclein affects dopamine metabolism and synaptic markers in the striatum of aging mice Neurobiol Aging 31 796 804 1:CAS:528: DC%2BC3cXjs1amurY%3D 10.1016/j.neurobiolaging.2008.11.001 19097673
66. H Zhao EKJ Tuominen PKJ Kinnunen 2004 Formation of amyloid fibers triggered by phosphatidylserine-containing membranes Biochem 43 10302 10307 1:CAS:528:DC%2BD2cXlslKrsr8%3D 10.1021/bi049002c (Pubitemid 39079303)
67. R Mozzi S Buratta G Goracci 2003 Metabolism and functions of phosphatidylserine in mammalian brain Neurochem Res 28 195 214 1:CAS:528:DC%2BD3sXhtVems7o%3D 10.1023/A:1022412831330 12608694 (Pubitemid 36207345)
68. C Sunshine MG McNamee 1992 Lipid modulation of nicotinic acetylcholine receptor function: the role of neutral and negatively charged lipids Biochim Biophys Acta 1108 240 246 1:CAS:528:DyaK38Xlt1Cktb4%3D 10.1016/0005-2736(92) 90031-G 1379073
69. MY Golovko TA Rosenberger S Feddersen NJ Faergeman EJ Murphy 2007 Alpha-synuclein gene ablation increases docosahexaenoic acid incorporation and turnover in brain phospholipids J Neurochem 101 201 211 1:CAS:528: DC%2BD2sXksFSqtr4%3D 10.1111/j.1471-4159.2006.04357.x 17250657 (Pubitemid 46426477)
70. WJ Lukiw NG Bazan 2008 Docosahexaenoic acid and the aging brain J Nutr 138 2510 2514 1:CAS:528:DC%2BD1cXhsVClsbrI 10.3945/jn.108.096016 19022980
71. H-Y Kim 2007 Novel metabolism of docosahexaenoic acid in neural cells J Biol Chem 282 18661 18665 1:CAS:528:DC%2BD2sXmvVarsrg%3D 10.1074/jbc.R700015200 17488715 (Pubitemid 47100128)